Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study

R. Teggi, B. Colombo, O. Gatti, G. Comi, M. Bussi

Research output: Contribution to journalArticlepeer-review

Abstract

Vestibular migraine (VM) is one of the most frequent causes of episodic vertigo, with a lifetime prevalence of 0.98 %. Prophylactic therapy includes calcium channel blockers, beta-blockers, antiepileptic drugs and antidepressants. We studied the association of cinnarizine 20 mg and dimenhydrinate 40 mg (Arlevertan

Original languageEnglish
Pages (from-to)1869-1873
Number of pages5
JournalNeurological Sciences
Volume36
Issue number10
DOIs
Publication statusPublished - Jun 3 2015

Keywords

  • Arlevertan
  • Calcium blockers
  • Prophylactic therapy
  • Vestibular migraine

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology

Fingerprint Dive into the research topics of 'Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study'. Together they form a unique fingerprint.

Cite this